Table 4.
Pearson coefficient “r” between serum irisin (IR) (T0–T3) level and somatic–functional parameters in four stages of cyclists’ macrocycles (T0–T3).
| Parameter/IR | IR T0 vs. | IR T1 vs. | IR T2 vs. | IR T3 vs. |
| BM *(T0–T3) | 0.101; p = 0.796 | −0.199; p = 0.609 | 0.174; p = 0.65 | 0.612; p = 0.080 |
| BMI (T0–T3) | 0.267; p = 0.488 | −0.211; p = 0.586 | −0.165; p = 0.671 | 0.588; p = 0.096 |
| FAT kg (T0–T3) | 0.222; p = 0.566 | 0.003; p = 0.994 | 0.228; p = 0.556 | 0.495; p = 0.176 |
| FAT% (T0–T3) | 0.264; p = 0.492 | 0.058; p = 0.882 | 0.234; p = 0.545 | 0.331; p = 0.385 |
| VO2max (T0–T3) | −0.441; p = 0.235 | −0.482; p = 0.189 | −0.101; p = 0.796 | −0.216; p = 0.578 |
| CK (T0–T3) | −0.319; p = 0.401 | −0.519; p = 0.152 | 0.353; p = 0.351 | 0.523; p = 0.148 |
| LDH (TO–T3) | −0.356; p = 0.342 | 0.448; p = 0.227 | −0.158; p = 0.685 | 0.372; p = 0.324 |
| MDA (T0–T3) | −0.035; p = 0.930 | −0.323; p = 0.397 | 0.333; p = 0.381 | 0.168; p = 0.666 |
| LA (T0–T3) | −0.163; p = 0.675 | 0.245; p = 0.525 | −0.224; p = 0.562 | 0.156; p = 0.688 |
| Pearson coefficient “r” between serum irisin (IR) level and WBC components, selected hormone concentrations and immunological factors in four stages of cyclists’ macrocycles (T0–T3). | ||||
| Parameter/IR | IR T0 vs. | IR T1 vs. | IR T2 vs. | IR T3 vs. |
| WBC (T0–T3) | −0.433; p = 0.244 | −0.418; p = 0.263 | −0.413; p = 0.269 | −0.455; p = 0.218 |
| Lymph (T0–T3) | −0.339; p = 0.372 | −0.620; p = 0.075 | −0.411; p = 0.272 | −0.269; p = 0.483 |
| Mono (T0–T3) | −0.159; p = 0.683 | −0.326; p = 0.391 | −0.111; p = 0.777 | −0.495; p = 0.176 |
| Neut (T0–T3) | −0.286; p = 0.455 | 0.105; p = 0.787 | −0.362; p = 0.38 | −0.173; p = 0.656 |
| Baso (T0–T3) | 0.011; p = 0.977 | −0.223; p = 0.564 | −0.646; p = 0.060 | −0.344; p = 0.365 |
| Eos (T0–T3) | −0.649; p = 0.058 | 0.085; p = 0.828 | 0.223; p = 0.564 | −0.177; p = 0.649 |
| Test (T0–T3) | 0.309; p = 0.418 | 0.178; p = 0.646 | −0.049; p = 0.901 | −0.238; p = 0.537 |
| Cort (T0–T3) | 0.758; p = 0.018 * | 0.304; p = 0.427 | 0.545; p = 0.129 | 0.544; p = 0.130 |
| T/C (T0–T3) | −0.220; p = 0.569 | 0.043; p = 0.913 | −0.278; p = 0.469 | −0.345; p = 0.363 |
| GH (T0–T3) | −0.230; p = 0.551 | −0.759; p = 0.018 * | −0.567; p = 0.111 | −0.527; p = 0.145 |
| IGF1 (T0–T3) | −0.417; p = 0.265 | −0.232; p = 0.548 | −0.236; p = 0.54 | −0.156; p = 0.689 |
| TNFα (T0–T3) | −0.303; p = 0.428 | 0.073; p = 0.851 | −0.559; p = 0.118 | −0.466; p = 0.206 |
| IL-6 (T0–T3) | −0.369; p = 0.328 | 0.289; p = 0.450 | 0.476; p = 0.195 | −0.053; p = 0.892 |
| CRP (T0–T3) | −0.152; p = 0.423 | 0.037; p = 0.924 | 0.00; p = 1.00 | 0.119; p = 0.761 |
| IgA (T0–T3) | −0.058; p = 0.882 | 0.203; p = 0.601 | 0.092; p = 0.813 | 0.551; p = 0.124 |
| IgG (T0–T3) | 0.325; p = 0.394 | 0.115; p = 0.768 | 0.188; p = 0.628 | 0.013; p = 0.974 |
| WBC (T0–T3) | −0.433; p = 0.244 | −0.418; p = 0.263 | −0.413; p = 0.269 | −0.455; p = 0.218 |
| Lymph (T0–T3) | −0.339; p = 0.372 | −0.620; p = 0.075 | −0.411; p = 0.272 | −0.269; p = 0.483 |